Form 8-K - Current report:
SEC Accession No. 0000950170-25-035482
Filing Date
2025-03-07
Accepted
2025-03-07 16:05:08
Documents
12
Period of Report
2025-03-07
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K atra-20250307.htm   iXBRL 8-K 45231
2 EX-99.1 atra-ex99_1.htm EX-99.1 292398
  Complete submission text file 0000950170-25-035482.txt   464167

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT atra-20250307.xsd EX-101.SCH 23888
14 EXTRACTED XBRL INSTANCE DOCUMENT atra-20250307_htm.xml XML 4539
Mailing Address 1280 RANCHO CONEJO BLVD THOUSAND OAKS CA 91320
Business Address 1280 RANCHO CONEJO BLVD THOUSAND OAKS CA 91320 805-623-4211
Atara Biotherapeutics, Inc. (Filer) CIK: 0001604464 (see all company filings)

EIN.: 460920988 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36548 | Film No.: 25719974
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)